Experience with pre‐diluted plasma exchange therapy for hyperviscosity syndrome
Therapeutic Apheresis and Dialysis · 2023
DOI: 10.1111/1744-9987.14053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2023. Verfasst von Shigeyuki Igarashi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Engineering, Fukui-ken Saiseikai Hospital, Fukui, Japan. Hauptthemen laut MEDLINE: Waldenstrom Macroglobulinemia, Multiple Myeloma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Introduction
Plasma exchange therapy (PE) is useful for patients with primary macroglobulinemia and multiple myeloma who present with hyperviscosity syndrome. However, hyperviscous blood may coagulate in the circuit during treatment, and in that case necessitate discontinuation of the treatment. This time, we report that we were able to prevent coagulation in the circuit by adding some ideas during the membrane separation method.
Methods
Physiological saline is injected in front of the plasma separation membrane to pre‐dilute the blood, followed by filtration through the plasma separation membrane.
Results
As a result of pre‐diluting with physiological saline to reduce the viscosity entering the separation membrane, it was possible to process the planned target amount.
Conclusion
In patients with hyperviscosity syndrome who showed intracircuit coagulation during plasma exchange therapy, devising a predilution method should be considered as one of the ways to continue treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Engineering, Fukui-ken Saiseikai Hospital, Fukui, Japan.
- Department of Internal Medicine, Fukui-ken Saiseikai Hospital, Fukui, Japan.
Zitieren
APA
Igarashi, S., Kamikawa, Y., Ono, S., Maekawa, G., Kishigami, H., Kawamura, K., Oonogi, T., & Nagano, T. (2023). Experience with pre‐diluted plasma exchange therapy for hyperviscosity syndrome. Therapeutic Apheresis and Dialysis. https://doi.org/10.1111/1744-9987.14053
Vancouver
Igarashi S, Kamikawa Y, Ono S, Maekawa G, Kishigami H, Kawamura K, et al. Experience with pre‐diluted plasma exchange therapy for hyperviscosity syndrome. Therapeutic Apheresis and Dialysis. 2023. doi:10.1111/1744-9987.14053
BibTeX
@article{Igarashi2023,
author = {Igarashi, Shigeyuki and Kamikawa, Yasutaka and Ono, Syuji and Maekawa, Gakuya and Kishigami, Hiroyuki and Kawamura, Kazuki and Oonogi, Takumi and Nagano, Toshihiko},
title = {Experience with pre‐diluted plasma exchange therapy for hyperviscosity syndrome},
journal = {Therapeutic Apheresis and Dialysis},
year = {2023},
doi = {10.1111/1744-9987.14053}
}
EUVIMED